bullish

Addex Therapeutics (ADXN.CH) - Wednesday, May 1, 2024

306 Views02 Aug 2024 10:44
Syndicated
SUMMARY
  • Addex is a stub allowing investors to invest in Neurosterix at a lower valuation
  • Neurosterix, backed by blue-chip VC firms, focuses on targeting muscarinic receptors for psychiatric disorders
  • Addex transferred assets to Neurosterix in exchange for equity, including an M4 PAM and an mGlu7R NAM

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x